The Mark Foundation for Cancer Research
North America, New York, United States, New York
Description
Mark Foundation actively partners with scientists to accelerate research that will transform the prevention, diagnosis, treatment of cancer.
Investor Profile
The Mark Foundation for Cancer Research has backed more than 12 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 8% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Seed rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Therapeutics, Health Care.
Stage Focus
- Series B (33%)
- Series A (25%)
- Seed (17%)
- Series C (8%)
- Series Unknown (8%)
- Grant (8%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Therapeutics
- Health Care
- Medical
- Biopharma
- Life Science
- Genetics
- Health Diagnostics
- Pharmaceutical
- Oncology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cg id='b'%3e%3cpath id='a' stroke='%23000' stroke-width='2' d='M-6-25H6m-12 3H6m-12 3H6'/%3e%3cuse xlink:href='%23a' y='44'/%3e%3c/g%3e%3cpath stroke='%23fff' d='M0 17v10'/%3e%3ccircle r='12' fill='%23cd2e3a'/%3e%3cpath fill='%230047a0' d='M0-12A6 6 0 0 0 0 0a6 6 0 0 1 0 12 12 12 0 0 1 0-24z'/%3e%3c/g%3e%3cg transform='rotate(-123.69)'%3e%3cuse xlink:href='%23b'/%3e%3cpath stroke='%23fff' d='M0-23.5v3M0 17v3.5m0 3v3'/%3e%3c/g%3e%3c/svg%3e)
